U.S. equity markets showed mixed performance this week, with technology and growth sectors declining sharply, including a 4.89% drop in tech stocks and a 3.11% fall in the NASDAQ 100 ETF. However, defensive and healthcare sectors provided support, helping to offset some losses. Notable stock momentum was seen in companies like Moderna, Applied Materials, and Bayer, which posted strong gains over the past 30 days. This mixed market suggests investors are rotating from growth to more defensive plays amid current conditions.
Wall Street ended the holiday-shortened week higher, driven by optimism over a potential Federal Reserve interest rate cut by year-end despite weaker-than-expected June jobs data. Technology stocks rebounded early in the week amid easing U.S.-Iran te...
Jim Cramer highlights Moderna's shift beyond Covid vaccines with a growing pipeline in cancer treatments and new vaccines, signaling a promising future. Despite shares being below their pandemic peak, the stock has surged nearly 150% this year, drive...
